STAND. COM. REP. NO. 799

 

Honolulu, Hawaii

, 2023

 

RE: H.B. No. 573

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirty-Second State Legislature

Regular Session of 2023

State of Hawaii

 

Sir:

 

Your Committee on Judiciary & Hawaiian Affairs, to which was referred H.B. No. 573 entitled:

 

"A BILL FOR AN ACT RELATING TO FENTANYL TEST STRIPS,"

 

begs leave to report as follows:

 

The purpose of this measure is to exclude fentanyl test strips from the definition of drug paraphernalia in the Controlled Substances Act.

 

Your Committee received testimony in support of this measure from the Department of Health, Hawaii Health & Harm Reduction Center, Drug Policy Forum of Hawaii, Community Alliance on Prisons, and nine individuals.

 

Your Committee finds that the Centers for Disease Control and Prevention and the Substance Abuse and Mental Health Services Administration encourage the use of federal funds to purchase fentanyl test strips to curb the dramatic spike in drug overdose deaths from the use of synthetic opioids that include illicitly manufactured fentanyl. Your Committee further finds that the Department of Health reported that there were seventy-four fatal opioid poisonings in Hawaii in 2021, fifty of which came from synthetic opioids that included fentanyl. This measure improves the prevention and reduction of drug overdoses in the State by allowing fentanyl test strips to be utilized as a valuable public health tool.

 

As affirmed by the record of votes of the members of your Committee on Judiciary & Hawaiian Affairs that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 573 and recommends that it pass Second Reading and be placed on the calendar for Third Reading.

 

 

Respectfully submitted on behalf of the members of the Committee on Judiciary & Hawaiian Affairs,

 

 

 

 

____________________________

DAVID A. TARNAS, Chair